1 / 67

General Meeting of the Global Alliance against Chronic Respiratory Diseases (GARD) and GARD Launch 28-29 March 2006 – Be

General Meeting of the Global Alliance against Chronic Respiratory Diseases (GARD) and GARD Launch 28-29 March 2006 – Beijing, People’s Republic of China Wednesday, 29 March 2006 Session 2 : Working Groups. Chairmanship, composition, 2005 annual report, 2006 action plan and indicators.

althea
Télécharger la présentation

General Meeting of the Global Alliance against Chronic Respiratory Diseases (GARD) and GARD Launch 28-29 March 2006 – Be

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. General Meeting of the Global Alliance against Chronic Respiratory Diseases (GARD) and GARD Launch 28-29 March 2006 – Beijing, People’s Republic of China Wednesday, 29 March 2006 Session 2: Working Groups. Chairmanship, composition, 2005 annual report, 2006 action plan and indicators

  2. The Lancet 2005;366:1514

  3. Horton, The Lancet 2005

  4. Horton, The Lancet 2005

  5. Horton, The Lancet 2005

  6. Strong et al, Lancet 2005

  7. Strong et al, Lancet 2005

  8. Strong et al, Lancet 2005

  9. Strong et al, Lancet 2005

  10. Epping-Jordan et al, Lancet 2005

  11. Reddy et al, Lancet 2005

  12. Fan Wu et al, Lancet 2005

  13. Presidents of respiratory societies participating in FIRS

  14. Chapman et al, ERJ 2006

  15. Chapman et al, ERJ 2006

  16. Chapman et al, ERJ 2006

  17. Chapman et al, ERJ 2006

  18. Chapman et al, ERJ 2006

  19. Lopez et al, ERJ 2006

  20. Lopez et al, ERJ 2006

  21. Lopez et al, ERJ 2006

  22. Lopez et al, ERJ 2006

  23. Lopez et al, ERJ 2006

  24. Lopez et al, ERJ 2006

  25. Mannino et al, ERJ 2006

  26. Mannino et al, ERJ 2006

  27. Menezes, Lancet 2005

  28. Respir Med. 2003 Feb;97(2):115-22. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K; Obstructive Lung Disease in Northern Sweden Studies.In 1996, 5892 of the Obstructive Lung Disease in Northern Sweden (OLIN) Study's first cohort could be traced to a third follow-up survey, and 5189 completed responses (88%) were received corresponding to 79% of the original cohort from December 1985. Of the responders, a random sample of 1500 subjects were invited to a structured interview and a lung function test, and 1237 of the invited completed a lung function test with acceptable quality. In ages >45 years, the prevalence of COPD according to the BTS guidelines was 8%, while it was 14% according to the GOLD criteria and approximately a half of elderly smokers fulfilled the criteria for COPD according to both the BTS and the GOLD criteria. Of those fulfilling the BTS criteria for COPD, 94% were symptomatics, 69% had chronic productive cough, but only 31% had prior to the study been diagnosed as having either chronic bronchitis, emphysema, or COPD. The corresponding figures for COPD according GOLD were 88, 51, and 18%.

  29. CHEST 2005

  30. Lindberg et al, CHEST 2005

  31. 2005

  32. Johannessen, IJTLD 2005

  33. WG-1: Epidemiology and Surveillance (G Viegi): Chair: G. Viegi, Italy (ERS); Co-Chairs: S. Buist, USA (GOLD), Y. Fukuchi (APSR). WHO-Liaison Officers: E. Mantsouranis. Proposed initial composition: I. Annesi (ERS), R. Beasley (?), P. Burney (GA2LEN), W. Canonica (WAO), B. Chipps (ACAAI), E. Duran (ERS), J. Jardim (ALAT), D.S. Kim (APSR), A. Kocabas (TTS), C. Lai (AAAF), Lee Todd (BOLD), B. Lundback (ERS), J. Mallol (?), D. Mannino (ATS?), D. Nugmanova (WONCA), J.A. Odhiambo (IUATLD?), R Pawankar (ARIA?), J Vestbo (ERS).

  34. 2005 Annual report The WG chairpersons have participated in the preparatory meetings held in Geneva and Copenhagen and have indicated the major needs in terms of epidemiology and surveillance of CRD and allergies. They have discussed the Terms of References of GARD. They have also identified the human resources needed to carry out the action plan, once the GARD budget has been established.

  35. General Objective The goal of this WG is to develop a standardized process to obtain data risk factors, disease burden, trends, quality and affordability of care and the economic burden of chronic respiratory diseases (CRD) and allergies that can then be compared across countries.

  36. Aims: • Use WHO programmes and non-WHO programmes to make an inventory of existing studies/reports that have collected data on prevalence, risk factors, severity, and economic burden of chronic respiratory diseases. • 2. Collect these data at a country-based level. • 3. Expand WHO internal initiatives (routine statistics, information systems, projection models) to cover respiratory and allergic diseases.

  37. Plan of work (I): • Develop the methodology and selection of key words. • 2. Review the literature published in the last 10 years. • 3. Calculate the PAR (Population Attributable Risk) for host and environmental factors. • 4. Include these data in the Info base of WHO.

  38. Plan of work (II): 5. Develop and test methods for estimating the economic burden of chronic respiratory diseases. 6. Validate the existing models aimed at forecasting disease prevalence and economic burden. 7. Identify standardized methods for prevalence surveys for the CRD of interest and establish standards for carrying out these surveys. 8. Develop risk charts for educational purposes.

More Related